BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Toru Ishikawa. Treatment Strategy for Recurrent Multiple Hepatocellular CarcinomaJournal of Cancer Therapy 2013; 4(02): 408 doi: 10.4236/jct.2013.42A049
2
Jean-Philippe Guégan, Frédéric Ezan, Nathalie Théret, Sophie Langouët, Georges Baffet. MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cellsCarcinogenesis 2013; 34(1): 38 doi: 10.1093/carcin/bgs317
3
HIROKI NISHIKAWA, YUKIO OSAKI, RYUICHI KITA, TORU KIMURA, YOSHIAKI OHARA, HARUHIKO TAKEDA, AZUSA SAKAMOTO, SUMIO SAITO, NORIHIRO NISHIJIMA, AKIHIRO NASU, HIDEYUKI KOMEKADO, SHUHEI NISHIGUCHI. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinomaOncology Reports 2014; 31(1): 65 doi: 10.3892/or.2013.2845
4
Shogo Ohkoshi. Interferon- β Augments the Effects of Cisplatin on Hcc Cell Lines by Regulating Sub Cellular Localization of P21Gastroenterology & Hepatology: Open Access 2015; 3(3) doi: 10.15406/ghoa.2015.03.00079
5
Hiroki Nishikawa, Yukio Osaki, Ryuichi Kita, Toru Kimura. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in JapanCancers 2012; 4(1): 165 doi: 10.3390/cancers4010165
6
HIROKI NISHIKAWA, YUKIO OSAKI, ERIKO IGUCHI, HARUHIKO TAKEDA, JUN NAKAJIMA, FUMIHIRO MATSUDA, AZUSA SAKAMOTO, SHINICHIRO HENMI, KEIICHI HATAMARU, SUMIO SAITO, AKIHIRO NASU, RYUICHI KITA, TORU KIMURA. Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinomaExperimental and Therapeutic Medicine 2012; 4(3): 381 doi: 10.3892/etm.2012.611
7
Qunying Zhuang, Tengjian Zhou, Chengyong He, Shili Zhang, Yang Qiu, Bing Luo, Ran Zhao, Hengchuan Liu, Yuchun Lin, Zhongning Lin. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133bJournal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0341-z
8
Liang-Tzung Lin, Chen-Jei Tai, Ching-Hua Su, Fang-Mo Chang, Chen-Yen Choong, Chien-Kai Wang, Cheng-Jeng Tai. The Ethanolic Extract ofTaiwanofungus camphoratus(Antrodia camphorata) Induces Cell Cycle Arrest and Enhances Cytotoxicity of Cisplatin and Doxorubicin on Human Hepatocellular Carcinoma CellsBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/415269
9
Kohei Ogawa, Kenya Kamimura, Yukari Watanabe, Yosuke Motai, Daisuke Kumaki, Ryoya Seki, Akira Sakamaki, Satoshi Abe, Hirokazu Kawai, Takeshi Suda, Satoshi Yamagiwa, Shuji Terai. Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two casesWorld Journal of Clinical Cases 2017; 5(6): 238-246 doi: 10.12998/wjcc.v5.i6.238
10
Masafumi Ikeda, Takuji Okusaka, Yozo Sato, Junji Furuse, Shuichi Mitsunaga, Hideki Ueno, Chigusa Morizane, Yoshitaka Inaba, Tatsushi Kobayashi, Yasuaki Arai. A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinomaJapanese Journal of Clinical Oncology 2017; 47(6): 512 doi: 10.1093/jjco/hyx038
11
Cheng-Jeng Tai, Wen-Ching Wang, Chien-Kai Wang, Chih-Hsiung Wu, Mei-Due Yang, Yu-Jia Chang, Jiun-Yu Jian, Chen-Jei Tai. Fermented Wheat Germ Extract Induced Cell Death and Enhanced Cytotoxicity of Cisplatin and 5-Fluorouracil on Human Hepatocellular Carcinoma CellsEvidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/121725
12
Dipak D. Meshram, Claire V.S. Pike, Peter J. Coussons. Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapyEuropean Journal of Pharmacology 2017; 815: 332 doi: 10.1016/j.ejphar.2017.09.035
13
Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular CarcinomaCancers 2019; 11(7): 986 doi: 10.3390/cancers11070986
14
Kenya Kamimura, Takeshi Suda, Takeshi Yokoo, Hiroteru Kamimura, Tsutomu Kanefuji, Atsunori Tsuchiya, Masaaki Takamura, Hirokazu Kawai, Nobuo Waguri, Satoshi Yamagiwa, Shuji Terai. Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trialBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3320-7
15
Dan Li, Xuefeng Liu, Jian Zhou, Jie Hu, Dongdong Zhang, Jing Liu, Yanyan Qiao, Qimin Zhan. Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesisHepatology 2017; 65(5): 1612 doi: 10.1002/hep.29010
16
Kenya Kamimura, Takeshi Suda, Yasushi Tamura, Masaaki Takamura, Takeshi Yokoo, Masato Igarashi, Hirokazu Kawai, Satoshi Yamagiwa, Minoru Nomoto, Yutaka Aoyagi. Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinomaBMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-127
17
Toru Ishikawa, Kazuo Higuchi, Tomoyuki Kubota, Keiichi Seki, Terasu Honma, Toshiaki Yoshida, Tomoteru Kamimura. Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/II hepatocellular carcinomaCancer 2011; 117(17): 4018 doi: 10.1002/cncr.25989